Towards a Global View of Parkinson's Disease Genetics

被引：3

作者：

Khani, Marzieh ^{[2
,3
]}

Cerquera-Cleves, Catalina ^{[4
,5
]}

Kekenadze, Mariam ^{[6
,7
]}

Crea, Peter Wild ^{[2
,3
]}

Singleton, Andrew B. ^{[2
,3
]}

Bandres-Ciga, Sara ^{[1
,2
,3
]}

机构：

[1] NIA, NIH, Ctr Alzheimers Dis & Related Dementias CARD, 9000 Rockville Pike,NIH Bldg T44, Bethesda, MD 20892 USA

[2] NIA, Ctr Alzheimers & Related Dementias CARD, Bethesda, MD USA

[3] NINDS, NIH, Bethesda, MD USA

[4] Pontificia Univ Javeriana, San Ignacio Hosp, Neurol Unit, Bogota, Colombia

[5] Laval Univ, CHU Quebec Res Ctr, Axe Neurosci, Quebec City, PQ, Canada

[6] Tbilisi State Med Univ, Tbilisi, Georgia

[7] UCL, Queen Sq Inst Neurol, London, England

来源：

ANNALS OF NEUROLOGY | 2024年 / 95卷 / 05期

基金：

美国国家卫生研究院;

关键词：

ALPHA-SYNUCLEIN; LRRK2; G2019S; GLUCOCEREBROSIDASE MUTATIONS; ASHKENAZI JEWS; PENETRANCE; RISK; PHENOTYPE; FREQUENCY; VPS35; DUPLICATION;

D O I：

10.1002/ana.26905

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Parkinson's disease (PD) is a global health challenge, yet historically studies of PD have taken place predominantly in European populations. Recent genetics research conducted in non-European populations has revealed novel population-specific genetic loci linked to PD risk, highlighting the importance of studying PD globally. These insights have broadened our understanding of PD etiology, which is crucial for developing disease-modifying interventions. This review comprehensively explores the global genetic landscape of PD, emphasizing the scientific rationale for studying underrepresented populations. It underscores challenges, such as genotype-phenotype heterogeneity and inclusion difficulties for non-European participants, emphasizing the ongoing need for diverse and inclusive research in PD. ANN NEUROL 2024

引用

下载

页码：831 / 842

页数：12

共 50 条

[21] Genetics of Parkinson's Disease
Kumar, Kishore R.
Djarmati-Westenberger, Ana
Gruenewald, Anne
SEMINARS IN NEUROLOGY, 2011, 31 (05) : 433 - 440
[22] Genetics of Parkinson's disease
Mizuno, Y
Hattori, N
Mori, H
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) : 109 - 116
[23] The genetics of Parkinson's disease
Spacey, SD
Wood, NW
CURRENT OPINION IN NEUROLOGY, 1999, 12 (04) : 427 - 432
[24] Genetics of Parkinson's disease
Thomas Gasser
Journal of Neurology, 2001, 248 : 833 - 840
[25] Genetics of Parkinson's disease
Morris, HR
ANNALS OF MEDICINE, 2005, 37 (02) : 86 - 96
[26] Genetics of Parkinson's disease
Gasser, T
JOURNAL OF NEUROLOGY, 2001, 248 (10) : 833 - 840
[27] The genetics of Parkinson's disease
de Silva, HA
Khan, NL
Wood, NW
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (03) : 292 - 298
[28] Genetics of Parkinson's disease
Gasser, T
CLINICAL GENETICS, 1998, 54 (04) : 259 - 265
[29] Genetics of Parkinson's disease: An introspection of its journey towards precision medicine
Bandres-Ciga, Sara
Diez-Fairen, Monica
Jeff Kim, Jonggeol
Singleton, Andrew B.
NEUROBIOLOGY OF DISEASE, 2020, 137
[30] Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)
Towns, Clodagh
Richer, Madeleine
Jasaityte, Simona
Stafford, Eleanor J.
Joubert, Julie
Antar, Tarek
Martinez-Carrasco, Alejandro
Makarious, Mary B.
Casey, Bradford
Levine, Kristin
Leonard, Hampton
Pantazis, Caroline B.
Screven, Laurel A.
Hernandez, Dena G.
Wegel, Claire E.
Solle, Justin
Nalls, Mike A.
Blauwendraat, Cornelis
Singleton, Andrew B.
Tan, Manuela M. X.
Iwaki, Hirotaka
Morris, Huw R.
NPJ PARKINSONS DISEASE, 2023, 9 (01)

← 1 2 3 4 5 →